Cite
HARVARD Citation
Bekaii-Saab, T. et al. (n.d.). O-014Regorafenib Dose Optimization Study (ReDOS): Randomized phase II trial to evaluate escalating dosing strategy and pre-emptive topical steroids for regorafenib in refractory metastatic colorectal cancer (mCRC) – An ACCRU Network study. Annals of oncology. p. . [Online].